Skip to main content
profilefund overviewpremium researchdividendsadv. chartsoptionsprice history

Virtus LifeSci Biotech Clinical Trials ETF News

Battered pharma stocks bounce back, could boost retirement portfolios

Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.

Five ‘Industries of the Future’ Investors Can’t Ignore

Robotics will be one of the dominant industries of the not too distant future and investors better take notice, said Alec Ross, author of The Industries of the Future.

Two ETF plays for when biotech stocks bounce back.

The lack of major drug launches last year, along with disappointing quarterly results, dragged down biotech stocks last year. The downtrend has continued into 2016.

Two ETFs to Play a Bounce Back in Biotech

The lack of major drug launches last year, along with disappointing quarterly results, dragged down biotech stocks last year but they could soon be headed higher.

Citigroup: Financial Winners and Losers

Citigroup was among the best performers of the financial sector Friday, rising after reports the bank has restarted efforts to unload its Japanese call center.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023